A new trial found that tricuspid transcatheter edge-to-edge repair (T-TEER) and optimized medical therapy (OMT) enhanced the ...

Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed.

Investigators saw more deaths in patients with severe TR after repeat mitral valve procedures; what to do about it is unclear ...

The S1 heart sound is two of your heart valves closing. It's the first sound doctors can hear with a stethoscope. Learn what ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement ...

Safe, effective one-year outcomes in severe tricuspid regurgitation, enhancing symptoms and reducing admissions.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Transcatheter tricuspid-valve replacement is superior to medical therapy alone for patients with severe tricuspid regurgitation, according to a study published online Oct. 30 in the New England ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid ... composite of all-cause mortality or tricuspid valve surgery, heart failure hospitalizations [HFH], and quality ...

The coaptation valve is positioned between the native tricuspid leaflets to fill the leaky area and prevent regurgitation. A novel anchor system leaves the right heart and native valve apparatus ...